Phaedra Chrousos
Director at Vanda Pharmaceuticals Inc. (VNDA)
Phaedra Chrousos has filed 7 insider reports with the SEC since June 2021, as director at Vanda Pharmaceuticals Inc. (VNDA). Phaedra Chrousos made no open-market purchases or sales in the last 12 months. The latest filing, on June 8, 2026, reports grant or award at Vanda Pharmaceuticals Inc. (VNDA).
- Filings
- 7
- Companies
- 1
- Bought on market
- None
- Sold on market
- $40.1K
Companies where Phaedra Chrousos is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 164,950 | $40.1K | $3.75 | Jun 8, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 4, 2026VNDADirector Chrousos Phaedra was granted 41,600 shares, increasing direct ownership by 34% to 164,950 unitsForm 4Grant or award
- Jun 5, 2025VNDADirector Chrousos Phaedra was granted 59,225 shares, increasing direct ownership by 92% to 123,350 unitsForm 4Grant or award
- May 22, 2024VNDAChrousos Phaedra was granted 21,887 shares, increasing direct ownership by 52% to 64,125 unitsForm 4Grant or award
- Jun 8, 2023VNDASEC Form 4 filed by Chrousos PhaedraForm 4Grant or award
- Jun 16, 2022VNDASEC Form 4: Chrousos Phaedra was granted 12,006 shares, increasing direct ownership by 93% to 24,931 unitsForm 4Grant or award
- Jun 14, 2021-$40.1KVNDASEC Form 4: Chrousos Phaedra sold $40,132 worth of Common Stock (2,075 units at $19.34), decreasing direct ownership by 14% to 12,925 units (withholding tax)Form 4Open-market sale
- Jun 10, 2021VNDASEC Form 4: Chrousos Phaedra was granted 5,000 units of Common Stock, increasing direct ownership by 50% to 15,000 unitsForm 4Grant or award
Compare Phaedra Chrousos with
- Phaedra Chrousos vs Charles Cliff Duncan1 shared
- Phaedra Chrousos vs Daniel Patrick McGuire1 shared
- Phaedra Chrousos vs Richard W Dugan1 shared
- Phaedra Chrousos vs Anne Sempowski Ward1 shared
- Phaedra Chrousos vs Tage Honore1 shared
- Phaedra Chrousos vs Stephen Ray Mitchell1 shared
Other insiders at the same companies
- Charles Cliff DuncanVNDA
- Daniel Patrick McGuireVNDA
- Richard W DuganVNDA
- Anne Sempowski WardVNDA
- Tage HonoreVNDA
- Stephen Ray MitchellVNDA
- Polymeropoulos Christos Vasilios MihaelVNDA
- Scott Laverne HowellVNDA
- Timothy WilliamsVNDA
- Kevin Patrick MoranVNDA
- Joakim WijkstromVNDA
- Mihael Hristos PolymeropoulosVNDA
- Gunther BirznieksVNDA
Questions about Phaedra Chrousos
- What is Phaedra Chrousos's role at Vanda Pharmaceuticals Inc.?
- Phaedra Chrousos reports to the SEC as director at Vanda Pharmaceuticals Inc. (VNDA), according to the latest filing on June 8, 2026.
- How many shares does Phaedra Chrousos own?
- After the latest filing that states it, Phaedra Chrousos directly owned 164,950 shares of Vanda Pharmaceuticals Inc. (VNDA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Phaedra Chrousos bought or sold stock recently?
- The most recent open-market sale was on June 14, 2021: sold 2,075 shares of Vanda Pharmaceuticals Inc. (VNDA) for $40.1K at an average of $19.34.
- How do I get alerts when Phaedra Chrousos files?
- Follow Phaedra Chrousos on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Phaedra Chrousos (SEC CIK 0001774518). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR